You are here

Home

Clinical Trials: Stroke and Related

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Wednesday, August 24, 2022 - 12:00
A Multicenter, Randomized Trial to Assess Safety, and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy
Conditions:   Hypoxic-Ischemic Encephalopathy;   Neonatal Asphyxia;   Neonatal Encephalopathy
Interventions:   Drug: Normal Saline along with standard treatment;   Drug: Sovateltide along with standard treatment
Sponsor:   Pharmazz, Inc.
Not yet recruiting
Posted: Wednesday, March 23, 2022 - 12:00
Stem Cell Infusion in the Treatment of Patients With Neurological Complications After Ischemic Stroke
Condition:   Ischemic Stroke
Interventions:   Biological: UC-MSC infusion via intravenous route;   Biological: UC-MSC infusion via intrathecal route;   Other: standard stroke treatment and rehabilitation therapy
Sponsor:   Vinmec Research Institute of Stem Cell and Gene Technology
Recruiting
Posted: Wednesday, December 15, 2021 - 12:00
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Stroke
Condition:   Stroke
Intervention:   Biological: AlloRx
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine
Recruiting
Posted: Tuesday, August 17, 2021 - 12:00
Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Sub-Acute Stroke Infarct
Condition:   Ischemic Stroke
Interventions:   Biological: Conditioned Medium;   Biological: Umbilical Cord Mesenchymal Stem Cells;   Procedure: Neurologic and Neutrophic Drugs
Sponsor:   PT. Prodia Stem Cell Indonesia
Not yet recruiting
Posted: Thursday, July 8, 2021 - 12:00
Clinical Plan of Ischemic Stroke
Condition:   Stroke
Intervention:   Biological: it-hMSC
Sponsor:   Peking University Third Hospital
Recruiting
Posted: Tuesday, March 23, 2021 - 12:00
Umbilical Cord-derived Mesenchymal Stem Cells for Ischemic Stroke
Condition:   Ischemic Stroke
Interventions:   Biological: Umbilical Cord-derived Mesenchymal Stem Cells;   Drug: Placebo
Sponsor:   General Hospital of Shenyang Military Region
Recruiting
Posted: Tuesday, November 17, 2020 - 12:00
A Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects With Chronic Ischemic Subcortical Stroke (ISS)
Condition:   Ischemic Stroke
Intervention:   Biological: Neural Stem Cells
Sponsor:   Gary Steinberg
Not yet recruiting
Posted: Thursday, October 29, 2020 - 12:00
A Randomized Placebo-controlled Multicenter Trial to Evaluate the Efficacy and Safety of JTR-161, Allogenic Human Dental Pulp Stem Cell, in Patients With Acute Ischemic stRoke (J-REPAIR)
Condition:   Acute Ischemic Stroke
Interventions:   Biological: JTR-161;   Biological: Placebo
Sponsor:   Teijin Pharma Limited
Recruiting
Posted: Monday, October 19, 2020 - 12:00
Allogeneic Mesenchymal Stem Cells for the Survivors of Ischemic Stroke Trial (ASSIST)
Condition:   Ischemic Stroke
Interventions:   Drug: it-hMSC;   Drug: Placebo
Sponsors:   Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd.;   Beijing Tiantan Hospital
Not yet recruiting
Posted: Tuesday, July 28, 2020 - 12:00
Study of the Therapeutic Effects of Cortical Autograft Implantation in Patients With Cerebral Ischemia
Condition:   Ischemic Stroke
Intervention:   Other: Autologous transplant
Sponsor:   Centre Hospitalier Universitaire Vaudois
Not yet recruiting

Pages